Document Detail


Insulin therapy does not interfere with venous endothelial function evaluation in patients with type 2 diabetes mellitus.
MedLine Citation:
PMID:  21243287     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Endothelium-dependent dilation is improved in insulin-treated diabetic patients, but this effect is probably due to improved glycemic control. The objective of the present study was to compare endothelium-dependent dilation in patients with well-controlled type 2 diabetes who are or are not using insulin as part of their therapy.
METHODS: We studied 27 patients with type 2 diabetes (11 women, 60.3 years ± 6 years, with HbA1c < 7% and no nephropathy), including 16 patients treated with anti-diabetic agents (No-Ins, 8 women) and 11 patients treated with insulin alone or in combination with anti-diabetic agents (Ins, 3 women). Endothelial function was evaluated by the dorsal hand vein technique, which measures changes in vein diameter in response to phenylephrine, acetylcholine (endothelium-dependent vasodilation) and sodium nitroprusside (endothelium-independent vasodilation).
RESULTS: Age, systolic blood pressure (No-Ins: 129.4 mmHg ± 11.8 mmHg, Ins: 134.8 mmHg ± 12.0 mmHg; P= 0.257), HbA1c, lipids and urinary albumin excretion rate [No-Ins: 9 mg/24 h (0-14.1 mg/24 h) vs. Ins: 10.6 mg/24 h (7.5-14.4 mg/24 h), P=0.398] were similar between groups. There was no difference between endothelium-dependent vasodilation of the No-Ins group (59.3% ± 26.5%) vs. the Ins group (54.0% ± 16.3%; P=0.526). Endothelium-independent vasodilation was also similar between the No-Ins (113.7% ± 35.3%) and Ins groups (111.9% ± 28.5%; P=0.888).
CONCLUSIONS: Subcutaneous insulin therapy does not interfere with venous endothelial function in type 2 diabetes when glycemic and blood pressure control are stable.
Authors:
Antônio Marcos Vargas da Silva; Luciana de Moraes Penno; Marcello Casaccia Bertoluci; Maria Cláudia Irigoyen; Beatriz D'Agord Schaan
Related Documents :
11433217 - Syringe, pen, inhaler - the evolution of insulin therapy.
17460767 - Alterations in somatostatin cells and biochemical parameters following zinc supplementa...
16432057 - Cardiac metallothionein induction plays the major role in the prevention of diabetic ca...
22641917 - The initial evaluation of the diabetic foot ulcer.
14512657 - Emphysematous perinephric abscess without diabetes or urinary obstruction.
2313607 - Quality of life in non-insulin-dependent diabetes and a comparison with insulin-depende...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinics (São Paulo, Brazil)     Volume:  65     ISSN:  1980-5322     ISO Abbreviation:  Clinics (Sao Paulo)     Publication Date:  2010  
Date Detail:
Created Date:  2011-01-18     Completed Date:  2011-10-14     Revised Date:  2013-07-02    
Medline Journal Info:
Nlm Unique ID:  101244734     Medline TA:  Clinics (Sao Paulo)     Country:  Brazil    
Other Details:
Languages:  eng     Pagination:  1139-42     Citation Subset:  IM    
Affiliation:
Departamento de Fisioterapia e Reabilitação, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Blood Pressure / drug effects
Diabetes Mellitus, Type 2 / drug therapy*,  physiopathology
Endothelium, Vascular / drug effects*,  physiology
Female
Humans
Hypoglycemic Agents / pharmacology*
Insulin / pharmacology*
Male
Middle Aged
Risk Factors
Statistics, Nonparametric
Vasodilation / drug effects*
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 0/Insulin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  High rate of viral identification and coinfections in infants with acute bronchiolitis.
Next Document:  Trends in ischemic heart disease and stroke death ratios in brazilian women and men.